These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

137 related articles for article (PubMed ID: 9801341)

  • 1. Preparation of a human standard for determination of the levels of antibodies to oxidatively modified low-density lipoproteins.
    Koskinen S; Enockson C; Lopes-Virella MF; Virella G
    Clin Diagn Lab Immunol; 1998 Nov; 5(6):817-22. PubMed ID: 9801341
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The preparation of copper-oxidized LDL for the measurement of oxidized LDL antibodies by EIA.
    Lopes-Virella MF; Koskinen S; Mironova M; Horne D; Klein R; Chassereau C; Enockson C; Virella G
    Atherosclerosis; 2000 Sep; 152(1):107-15. PubMed ID: 10996345
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Autoantibodies against oxidized low density lipoproteins (oxLDL): characterization of antibody isotype, subclass, affinity and effect on the macrophage uptake of oxLDL.
    Wu R; Lefvert AK
    Clin Exp Immunol; 1995 Oct; 102(1):174-80. PubMed ID: 7554386
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Antibodies to oxidized LDL and LDL-containing immune complexes as risk factors for coronary artery disease in diabetes mellitus.
    Lopes-Virella MF; Virella G; Orchard TJ; Koskinen S; Evans RW; Becker DJ; Forrest KY
    Clin Immunol; 1999 Feb; 90(2):165-72. PubMed ID: 10080827
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Evaluation and characterization of EIA measuring autoantibodies against oxidized LDL.
    Närvänen O; Erkkilä A; Ylä-Herttuala S
    Free Radic Biol Med; 2001 Sep; 31(6):769-77. PubMed ID: 11557315
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Increased levels of autoantibodies against copper-oxidized low density lipoprotein, malondialdehyde-modified low density lipoprotein and cardiolipin in patients with rheumatoid arthritis.
    Cvetkovic JT; Wållberg-Jonsson S; Ahmed E; Rantapää-Dahlqvist S; Lefvert AK
    Rheumatology (Oxford); 2002 Sep; 41(9):988-95. PubMed ID: 12209031
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Immunochemical characterization of purified human oxidized low-density lipoprotein antibodies.
    Virella G; Koskinen S; Krings G; Onorato JM; Thorpe SR; Lopes-Virella M
    Clin Immunol; 2000 May; 95(2):135-44. PubMed ID: 10779407
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Locally produced anti-phosphorylcholine and anti-oxidized low-density lipoprotein antibodies in gingival crevicular fluid from aggressive periodontitis patients.
    Schenkein HA; Berry CR; Burmeister JA; Brooks CN; Best AM; Tew JG
    J Periodontol; 2004 Jan; 75(1):146-53. PubMed ID: 15025226
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Anti-oxidized low-density lipoprotein (oxLDL) antibody levels are not related to increasing circulating oxLDL concentrations during the course of pregnancy.
    Pecks U; Tillmann D; Ernst S; Maass N; Meinhold-Heerlein I
    Am J Reprod Immunol; 2012 Oct; 68(4):345-52. PubMed ID: 22594315
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Anti-oxidized low-density lipoprotein antibodies in myeloperoxidase-positive vasculitis patients preferentially recognize hypochlorite-modified low density lipoproteins.
    Slot MC; Theunissen R; van Paassen P; Damoiseaux JG; Tervaert JW;
    Clin Exp Immunol; 2007 Aug; 149(2):257-64. PubMed ID: 17521320
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Cerebrospinal fluid antibodies to oxidized LDL are increased in Alzheimer's disease.
    Kankaanpää J; Turunen SP; Moilanen V; Hörkkö S; Remes AM
    Neurobiol Dis; 2009 Mar; 33(3):467-72. PubMed ID: 19130885
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Autoantibodies against oxidatively-modified LDL in uremic patients undergoing dialysis.
    Maggi E; Bellazzi R; Gazo A; Seccia M; Bellomo G
    Kidney Int; 1994 Sep; 46(3):869-76. PubMed ID: 7996809
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Direct evidence for a protein recognized by a monoclonal antibody against oxidatively modified LDL in atherosclerotic lesions from a Watanabe heritable hyperlipidemic rabbit.
    Boyd HC; Gown AM; Wolfbauer G; Chait A
    Am J Pathol; 1989 Nov; 135(5):815-25. PubMed ID: 2683796
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Development of capture assays for different modifications of human low-density lipoprotein.
    Virella G; Derrick MB; Pate V; Chassereau C; Thorpe SR; Lopes-Virella MF
    Clin Diagn Lab Immunol; 2005 Jan; 12(1):68-75. PubMed ID: 15642987
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Anti-oxidized low-density lipoprotein antibodies in patients with coronary heart disease and normal healthy volunteers.
    Virella G; Virella I; Leman RB; Pryor MB; Lopes-Virella MF
    Int J Clin Lab Res; 1993; 23(2):95-101. PubMed ID: 8518420
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Oxidized low-density lipoprotein autoantibodies, chronic infections, and carotid atherosclerosis in a population-based study.
    Mayr M; Kiechl S; Tsimikas S; Miller E; Sheldon J; Willeit J; Witztum JL; Xu Q
    J Am Coll Cardiol; 2006 Jun; 47(12):2436-43. PubMed ID: 16781371
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Anti-ox-LDL antibodies and anti-ox-LDL-B2GPI antibodies in patients with systemic lupus erythematosus.
    Nowak B; Szmyrka-Kaczmarek M; Durazińska A; Płaksej R; Borysewicz K; Korman L; Wiland P
    Adv Clin Exp Med; 2012; 21(3):331-5. PubMed ID: 23214196
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The low-density lipoprotein (LDL)-associated PAF-acetylhydrolase activity and the extent of LDL oxidation are important determinants of the autoantibody titers against oxidized LDL in patients with coronary artery disease.
    Lourida ES; Papathanasiou AI; Goudevenos JA; Tselepis AD
    Prostaglandins Leukot Essent Fatty Acids; 2006 Aug; 75(2):117-26. PubMed ID: 16843649
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Percutaneous coronary intervention results in acute increases in oxidized phospholipids and lipoprotein(a): short-term and long-term immunologic responses to oxidized low-density lipoprotein.
    Tsimikas S; Lau HK; Han KR; Shortal B; Miller ER; Segev A; Curtiss LK; Witztum JL; Strauss BH
    Circulation; 2004 Jun; 109(25):3164-70. PubMed ID: 15184281
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Antibodies against human oxidized low-density lipoprotein (LDL) as markers for human plasma modified lipoproteins.
    Radulescu L; Stancu C; Antohe F
    Med Sci Monit; 2004 Jul; 10(7):BR207-14. PubMed ID: 15232494
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.